ArticleFacts, views & vision in ObGyn2025
Improving efficacy and safety of surgery in benign gynaecology: the case for indocyanine green.
Article in Facts, views & vision in ObGyn, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Intra-ureteric indocyanine green for ureteric visualisation in complex benign gynaecological surgery: a prospective series of 50 cases.Facts, views & vision in ObGyn · 2026Article
- Illuminating the surgical field: the expanding role of Indocyanine Green (ICG) in gynaecological surgery.Facts, views & vision in ObGyn · 2026Article
- Fluorescence-Guided Bladder and Ureter Visualization in Benign Robotic Gynecologic Surgery: A Series of Five Cases.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indocyanine green (ICG) with near-infrared imaging is a valuable adjunct in minimally invasive gynaecological surgery, enhancing anatomical visualisation and surgical precision. This narrative review synthesises current evidence on ICG's clinical applications, safety, and practical implementation in benign gynaecology. ICG supports bladder and ureteric identification, cavity integrity checks, and assessment of bowel and ovarian perfusion. It also aids detection of endometriosis lesions, though diagnostic accuracy remains variable. ICG is safe and feasible, with growing evidence supporting its role across a range of procedures. Further research is needed to standardise protocols, assess cost-effectiveness, and support broader adoption in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.